so following up from that:
It's not yet clear what sort of reimbursement PIQ/SHL can expect per test. This may still be in the works with providers.
But to me it seems that from April 1 has the potential to see an upturn in revenue.
However I would have thought it would make sense that the deal between SHL and PIQ should be hammered in place by this point.
Ann: US update - PromarkerD licensing negotiations, page-19
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.42M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 28.5¢ | $187.1K | 634.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 81754 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 15.57pm 27/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |